ACCESSION: MSBNK-SMB_Measured-HSA001P0216000
RECORD_TITLE: Characterized; 1-(2-piperazin-1-ylethyl)piperazine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 26
COMMENT: RAW_SPEC {'BLK01_6765': {'bp': 856043.0, 'sum': 2289383.0}, 'BLK01_6910': {'bp': 837783.0, 'sum': 2287429.0}, 'BLK01_7103': {'bp': 821682.0, 'sum': 2299831.0}, 'BLK01_6703': {'bp': 793113.0, 'sum': 2022885.0}, 'BLK01_6852': {'bp': 777006.0, 'sum': 2038661.0}, 'BLK01_6611': {'bp': 750029.0, 'sum': 1923059.0}, 'BLK01_7040': {'bp': 745888.0, 'sum': 2011959.0}, 'BLK01_6535': {'bp': 740353.0, 'sum': 1905857.0}, 'BLK02_6570': {'bp': 720924.0, 'sum': 1800198.0}, 'BLK01_7164': {'bp': 715057.0, 'sum': 2010273.0}, 'BLK01_6975': {'bp': 712808.0, 'sum': 1881614.0}, 'BLK01_7228': {'bp': 685283.0, 'sum': 1882697.0}, 'BLK02_6484': {'bp': 661212.0, 'sum': 1682164.0}, 'BLK02_6764': {'bp': 650324.0, 'sum': 1609677.0}, 'BLK02_6640': {'bp': 646773.0, 'sum': 1674219.0}, 'BLK02_6702': {'bp': 630676.0, 'sum': 1627142.0}, 'BLK02_6977': {'bp': 585712.0, 'sum': 1492121.0}, 'BLK02_6828': {'bp': 572033.0, 'sum': 1530466.0}, 'BLK02_7137': {'bp': 565610.0, 'sum': 1461475.0}, 'BLK02_6908': {'bp': 520495.0, 'sum': 1423337.0}, 'BLK02_7222': {'bp': 491494.0, 'sum': 1324243.0}, 'ProcedureBlank_6719': {'bp': 491248.0, 'sum': 1208406.0}, 'ProcedureBlank_6486': {'bp': 460098.0, 'sum': 1152076.0}, 'ProcedureBlank_6614': {'bp': 446293.0, 'sum': 1111026.0}, '1_posi_6656': {'bp': 421821.0, 'sum': 1050870.0}, 'ProcedureBlank_7202': {'bp': 358380.0, 'sum': 977928.0}}
COMMENT: RETENTION_TIME_STDEV 0.478
COMMENT: PRECURSOR_M/Z_RAW 216.217870
COMMENT: PRECURSOR_M/Z_STDEV 0.000047
COMMENT: PRECURSOR_IN_MS1 mz 216.218258; int 117.879; delta(ppm) 1.126967
COMMENT: PROPOSED_CHARGE_STATE +1; mz 217.221483; int 11.056; cor 0.774
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+NH4; M+H; mz 199.191666; int 16.256; cor 0.679
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.102; C10H25N5; [M+H]+; delta(ppm) -0.102225
COMMENT: PROPOSED_MF SevenGoldenRules 0.101; C10H22N4; [M+NH4]+; delta(ppm) -0.100916
COMMENT: PROPOSED_MF MS-FINDER 3.059; C10H22N4; [M+NH4]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF MS-FINDER 2.371; C10H25N5; [M+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF SIRIUS5_Sirius 33.650; C10H25N5; [M+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF SIRIUS5_Sirius 33.650; C10H22N4; [M+H3N+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H25N5; [M+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H22N4; [M+H3N+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF SIRIUS6_Sirius 66.060; C10H22N4; [M+H3N+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF SIRIUS6_Sirius 66.060; C10H25N5; [M+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF SIRIUS6_Sirius 52.828; C12H24NO; [M+H3N+H]+; delta(ppm) -6.312702
COMMENT: PROPOSED_MF SIRIUS6_Sirius 52.828; C12H27N2O; [M+H]+; delta(ppm) -6.312702
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H22N4; [M+H3N+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H25N5; [M+H]+; delta(ppm) -0.102981
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.671; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+NH4]+; Guanethidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.257; VVZPFWHJZRAHKY-UHFFFAOYSA-N; [M+NH4]+; N-{4-[(3-methylbut-1-en-1-yl)amino]butyl}guanidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.133; SJNDFAUBUWEBDR-UHFFFAOYSA-N; [M+NH4]+; CNP0444498
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VVZPFWHJZRAHKY-UHFFFAOYSA-N; [M+NH4]+; N-{4-[(3-methylbut-1-en-1-yl)amino]butyl}guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.992; SJNDFAUBUWEBDR-UHFFFAOYSA-N; [M+NH4]+; CNP0444498
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.865; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+NH4]+; Guanethidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.869; ACGDKVXYNVEAGU-UHFFFAOYSA-N; [M+NH4]+; 2-[2-(azocan-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; LPOUQGUYVMSQOH-UHFFFAOYSA-N; [M+H]+; N'-[2-(2-piperazin-1-ylethylamino)ethyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.887; KDCBVVQAMMXRFB-UHFFFAOYSA-N; [M+H]+; 1,4,7,10,13-pentazacyclopentadecane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.782; CXNQJNPKMZRHBC-UHFFFAOYSA-N; [M+H]+; N'-[2-[4-(2-aminoethyl)piperazin-1-yl]ethyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; XDHVNMPVLPEHND-UHFFFAOYSA-N; [M+NH4]+; 1-(2-piperazin-1-ylethyl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.066; LLQZZBARQZBNEH-UHFFFAOYSA-N; [M+NH4]+; 2-[3-(3-methylpiperidin-1-yl)propyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; ILZNQIXWPJXOCK-UHFFFAOYSA-N; [M+NH4]+; 2-[2-[cyclohexyl(methyl)amino]ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; QGLNJLLUIYNAEO-DTORHVGOSA-N; [M+NH4]+; 2-[2-[(2R,6S)-2,6-dimethylpiperidin-1-yl]ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; KDIMDNGDUIGURW-UHFFFAOYSA-N; [M+NH4]+; 2-[2-(4-methylazepan-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; VACJHYSOFQSYAC-UHFFFAOYSA-N; [M+NH4]+; 1-(4-aminobutyl)-2-(3-methylbut-2-enyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.750; LZELKEGDAZZHMY-UHFFFAOYSA-N; [M+NH4]+; N'-[8-(aminomethylideneamino)octyl]methanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -12.089; KDCBVVQAMMXRFB; [M+H]+; [15]anen5
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -17.603; XDHVNMPVLPEHND; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -18.601; CXNQJNPKMZRHBC; [M+H]+; N-(2-Aminoethyl)piperazin-1,4-diethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -25.000; LPOUQGUYVMSQOH; [M+H]+; N''-[2-(2-piperazin-1-ylethylamino)ethyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -76.866; JHTHWQGESSFWFP; [M+H3N+H]+; 6-Spermyne
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.432; ACGDKVXYNVEAGU; [M+H3N+H]+; Eutensol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.807; VACJHYSOFQSYAC; [M+H3N+H]+; N-Prenyl Agmatine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.500; QGLNJLLUIYNAEO; [M+H3N+H]+; 2-[2-(2,6-dimethylpiperidin-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.275; BNYZYAWCGAEIKT; [M+H3N+H]+; Spherophysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -273.537; VVZPFWHJZRAHKY; [M+H3N+H]+; 2-[4-(3-methylbut-1-enylamino)butyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -320.635; SJNDFAUBUWEBDR; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.685; XDHVNMPVLPEHND; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.416; KDCBVVQAMMXRFB; [M+H]+; [15]anen5
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -9.583; KDCBVVQAMMXRFB; [M+H]+; 1,4,7,10,13-Pentaazacyclopentadecane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -37.618; XDHVNMPVLPEHND; [M+H3N+H]+; Piperazine, 1,1'-(1,2-ethanediyl)bis-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -68.311; LPOUQGUYVMSQOH; [M+H]+; N-(2-Aminoethyl)-N'-(2-(1-piperazinyl)ethyl)ethylenediamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -82.888; CXNQJNPKMZRHBC; [M+H]+; N1-(2-(4-(2-aminoethyl)piperazin-1-yl)ethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -111.441; JHTHWQGESSFWFP; [M+H3N+H]+; 2-Butyne-1,4-diamine, N,N'-bis(3-aminopropyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -186.091; VVZPFWHJZRAHKY; [M+H3N+H]+; N-{4-[(3-methylbut-1-en-1-yl)amino]butyl}guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.763; VACJHYSOFQSYAC; [M+H3N+H]+; N-(4-aminobutyl)-N'-(3-methylbut-2-en-1-yl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -215.806; ACGDKVXYNVEAGU; [M+H3N+H]+; N-[2-(azocan-1-yl)ethyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -234.053; BNYZYAWCGAEIKT; [M+H3N+H]+; Spherophysine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -235.312; SJNDFAUBUWEBDR; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.917; QGLNJLLUIYNAEO; [M+H3N+H]+; 2-[2-[(2S,6R)-2,6-dimethylpiperidin-1-yl]ethyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.733; KDCBVVQAMMXRFB; [M+H]+; 1,4,7,10,13-Pentaazacyclopentadecane
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.396; XDHVNMPVLPEHND; [M+H3N+H]+; Piperazine, 1,1'-(1,2-ethanediyl)bis-
COMMENT: CONFIDENCE Level 3: Tentative candidate, nan, XDHVNMPVLPEHND-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (10); This structural isomer was suggested from the biological context HMDB HMDB0000214;HMDB0003374;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H22N4
CH$EXACT_MASS: 198.184447
CH$SMILES: C1CN(CCN1)CCN2CCNCC2
CH$IUPAC: InChI=1S/C10H22N4/c1-5-13(6-2-11-1)9-10-14-7-3-12-4-8-14/h11-12H,1-10H2
CH$NAME: 1,1â€²-(1,2-Ethanediyl)bis[piperazine]
CH$NAME: 1-(2-piperazin-1-ylethyl)piperazine
CH$LINK: INCHIKEY XDHVNMPVLPEHND-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:88087
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 13.699
MS$FOCUSED_ION: ION_TYPE [M+NH4]+
MS$FOCUSED_ION: PRECURSOR_M/Z 216.218250
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-1980000000-e85f3fe0d4c77bfcf585
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  70.0650863 10.9269 70.065706 1.7841 2.54 0.6104 24 f{C4H8N1}/-0.56ppm,p-C6H18N4
  72.0806987 20.2198 72.081305 1.2763 4.37 0.7039 26 f{C4H10N1}/-1.07ppm,p-C6H16N4
  84.0806622 9.2413 84.081154 2.1646 2.44 0.5596 19 f{C5H10N1}/-1.35ppm,p-C5H16N4
  85.0759138 19.2719 85.076393 1.0814 3.90 0.7969 26 f{C4H9N2}/-1.30ppm,p-C6H17N3
  86.0600018 22.0668 86.060468 1.1155 4.34 0.8537 26 ?
  87.0917092 96.6760 87.092162 0.5052 14.26 0.9371 26 f{C4H11N2}/0.40ppm,p-C6H15N3
  104.1182586 31.4669 104.118544 1.3254 5.00 0.8161 26 ?
  111.0917113 64.7836 111.091927 0.6571 8.59 0.7928 26 f{C6H11N2}/0.33ppm,p-C4H15N3
  113.1073487 322.9827 113.107542 0.2476 16.10 0.9569 26 f{C6H13N2}/0.21ppm,p-C4H13N3
  115.1229927 37.6308 115.123163 1.1553 6.04 0.7730 26 f{C6H15N2}/0.15ppm,p-C4H11N3
  128.1182879 32.9609 128.118285 1.3347 5.18 0.8482 26 f{C6H14N3}/0.50ppm,p-C4H12N2
  130.0862608 14.5565 130.086229 2.1909 3.68 0.7470 26 ?
  130.1339355 206.3603 130.133903 0.3919 15.14 0.9480 26 f{C6H16N3}/0.47ppm,p-C4H10N2
  131.0814468 11.5375 131.081400 1.9454 2.84 0.8221 21 ?
  132.1495639 66.5980 132.149500 0.8475 9.31 0.7703 26 f{C6H18N3}/0.30ppm,p-C4H8N2
  156.1495876 291.5805 156.149482 0.4163 20.58 0.9015 26 f{C8H18N3}/0.41ppm,p-C2H8N2
  173.1761749 17.3204 173.176058 1.8536 3.51 0.7365 24 f{C8H21N4}/0.59ppm,p-C2H5N1
  198.1239462 19.1286 198.123814 1.9281 4.77 0.7463 26 ?
  199.1919461 62.5181 199.191813 1.1396 6.26 0.9015 26 f{C10H23N4}/1.12ppm,p-H3N1
  216.1361227 67.3357 216.135979 2.7945 17.06 0.6515 25 ?
  216.1724263 67.9462 216.172282 3.1133 15.91 0.3015 25 ?
  216.2183697 999.0000 216.218226 0.2174 0.00 1.0000 26 f{C10H26N5}/0.45ppm,p
PK$NUM_PEAK: 22
PK$PEAK: m/z int. rel.int.
  70.065086 10.93 10
  72.080699 20.22 20
  84.080662 9.24 9
  85.075914 19.27 19
  86.060002 22.07 22
  87.091709 96.68 96
  104.118259 31.47 31
  111.091711 64.78 64
  113.107349 322.98 322
  115.122993 37.63 37
  128.118288 32.96 32
  130.086261 14.56 14
  130.133935 206.36 206
  131.081447 11.54 11
  132.149564 66.60 66
  156.149588 291.58 291
  173.176175 17.32 17
  198.123946 19.13 19
  199.191946 62.52 62
  216.136123 67.34 67
  216.172426 67.95 67
  216.218370 999.00 999
//
